Pharmacokinetics of Rifapentine in Patients with Varying Degrees of Hepatic Dysfunction

In this open‐label investigation, the pharmacokinetics of rifapentine and its active metabolite, 25‐desacetyl‐rifapentine, were characterized in patients with varying degrees of hepatic dysfunction. Eight patients with mild‐to‐moderate chronic, stable hepatic dysfunction and seven patients with mode...

Ausführliche Beschreibung